These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30548546)

  • 1. A case of pan-resistant Burkholderia cepacia complex bacteremic pneumonia, after lung transplantation treated with a targeted combination therapy.
    Cantón-Bulnes ML; Hurtado Martínez Á; López-Cerero L; Arenzana Seisdedos Á; Merino-Bohorquez V; Garnacho-Montero J
    Transpl Infect Dis; 2019 Apr; 21(2):e13034. PubMed ID: 30548546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful ceftazidime-avibactam treatment of post-surgery Burkholderia multivorans genomovar II bacteremia and brain abscesses in a young lung transplanted woman with cystic fibrosis.
    Daccò V; Claut L; Piconi S; Castellazzi L; Garbarino F; Teri A; Colombo C
    Transpl Infect Dis; 2019 Jun; 21(3):e13082. PubMed ID: 30892778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung transplantation in two cystic fibrosis patients infected with previously pandrug-resistant Burkholderia cepacia complex treated with ceftazidime-avibactam.
    Los-Arcos I; Len O; Martín-Gómez MT; González-López JJ; Saéz-Giménez B; Deu M; Nuvials X; Ferrer R; Román A; Gavaldà J
    Infection; 2019 Apr; 47(2):289-292. PubMed ID: 30565008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel antibiotic combinations proposed for treatment of
    El-Halfawy OM; Naguib MM; Valvano MA
    Antimicrob Resist Infect Control; 2017; 6():120. PubMed ID: 29204272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and outcomes of non-cystic fibrosis patients with Burkholderia cepacia complex bacteremia at a medical center in Taiwan.
    Chang TH; Chuang YC; Wang JT; Sheng WH
    J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 2):1301-1309. PubMed ID: 34674957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of ceftazidime/avibactam for the treatment of MDR Pseudomonas aeruginosa and Burkholderia cepacia complex infections in cystic fibrosis: a case series.
    Spoletini G; Etherington C; Shaw N; Clifton IJ; Denton M; Whitaker P; Peckham DG
    J Antimicrob Chemother; 2019 May; 74(5):1425-1429. PubMed ID: 30649419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
    Horsley A; Jones AM
    Cochrane Database Syst Rev; 2012 Oct; 10():CD009529. PubMed ID: 23076960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftazidime plasma concentration in a patient with cystic fibrosis treated with ceftazidime/avibactam plus trimethoprim/sulfametoxazole for
    Saffioti C; Barco S; Cangemi G; Mesini A; Casciaro R; Cresta F; Castellani C; Bandettini R; Morelli P; Castagnola E
    J Chemother; 2019; 31(7-8):436-438. PubMed ID: 31583970
    [No Abstract]   [Full Text] [Related]  

  • 9. Implementation of a successful eradication protocol for Burkholderia Cepacia complex in cystic fibrosis patients.
    Garcia BA; Carden JL; Goodwin DL; Smith TA; Gaggar A; Leon K; Antony VB; Rowe SM; Solomon GM
    BMC Pulm Med; 2018 Feb; 18(1):35. PubMed ID: 29444656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empiric treatment of multidrug-resistant Burkholderia cepacia lung exacerbation in a patient with cystic fibrosis: application of pharmacodynamic concepts to meropenem therapy.
    Kuti JL; Moss KM; Nicolau DP; Knauft RF
    Pharmacotherapy; 2004 Nov; 24(11):1641-5. PubMed ID: 15537567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre.
    Dobbin C; Maley M; Harkness J; Benn R; Malouf M; Glanville A; Bye P
    J Hosp Infect; 2004 Apr; 56(4):277-82. PubMed ID: 15066737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis.
    Zhou J; Chen Y; Tabibi S; Alba L; Garber E; Saiman L
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1085-8. PubMed ID: 17158942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosis.
    Kitt H; Lenney W; Gilchrist FJ
    BMC Pharmacol Toxicol; 2016 Mar; 17():14. PubMed ID: 27018049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival following Burkholderia cepacia sepsis in a patient with cystic fibrosis treated with corticosteroids.
    Kazachkov M; Lager J; LiPuma J; Barker PM
    Pediatr Pulmonol; 2001 Oct; 32(4):338-40. PubMed ID: 11568995
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Singh P; Patro S; Deep A; Mohapatra SK
    Trop Doct; 2023 Apr; 53(2):303-304. PubMed ID: 36916218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and microbiological profile of chronic Burkholderia cepacia complex infections in a cystic fibrosis reference hospital in Brazil.
    da Costa Capizzani CP; Caçador NC; Torres LAGMM; Tonani L; Vandamme P; da Costa Darini AL
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2263-2271. PubMed ID: 28840370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience.
    De Soyza A; Meachery G; Hester KL; Nicholson A; Parry G; Tocewicz K; Pillay T; Clark S; Lordan JL; Schueler S; Fisher AJ; Dark JH; Gould FK; Corris PA
    J Heart Lung Transplant; 2010 Dec; 29(12):1395-404. PubMed ID: 20810293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis Patients.
    Papp-Wallace KM; Becka SA; Zeiser ET; Ohuchi N; Mojica MF; Gatta JA; Falleni M; Tosi D; Borghi E; Winkler ML; Wilson BM; LiPuma JJ; Nukaga M; Bonomo RA
    ACS Infect Dis; 2017 Jul; 3(7):502-511. PubMed ID: 28264560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burkholderia cepacia complex: impact on the cystic fibrosis lung lesion.
    Lynch JP
    Semin Respir Crit Care Med; 2009 Oct; 30(5):596-610. PubMed ID: 19760547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of cepacia syndrome with a combination of intravenous cyclosporin, antibiotics and oral corticosteroids.
    Gilchrist FJ; Webb AK; Bright-Thomas RJ; Jones AM
    J Cyst Fibros; 2012 Sep; 11(5):458-60. PubMed ID: 22551926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.